TCL Archive President Proposes 2.1% Incerase for NIH, 2.4% Increase for NCI, In Year 2000 Budget February 5, 1999
TCL Archive EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation May 30, 2014